13F HOLDINGS REPORT
DIADEMA PARTNERS LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001892688-25-000086
Total Value
$233.1M
Positions
107
Other Managers
0
Confidential Omitted
No
Holdings (107)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERTEX PHARMACEUTICALS INC | VRTX | 57,400 | $23.1M | 9.92% |
| 2 | SPDR SER TR | 78464A870 | 200,000 | $18.0M | 7.73% |
| 3 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 160,000 | $9.0M | 3.88% |
| 4 | ABBVIE INC | ABBV | 50,000 | $8.9M | 3.81% |
| 5 | ABBVIE INC | ABBV | 50,000 | $8.9M | 3.81% |
| 6 | SOLENO THERAPEUTICS INC | SLNO | 175,400 | $7.9M | 3.38% |
| 7 | ARCELLX INC | ACLX | 100,000 | $7.7M | 3.29% |
| 8 | CRISPR THERAPEUTICS AG | CRSP | 190,800 | $7.5M | 3.22% |
| 9 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 300,000 | $6.7M | 2.86% |
| 10 | TG THERAPEUTICS INC | TGTX | 200,000 | $6.0M | 2.58% |
| 11 | BLUEPRINT MEDICINES CORP | 09627Y109 | 64,193 | $5.6M | 2.40% |
| 12 | HALOZYME THERAPEUTICS INC | HALO | 100,000 | $4.8M | 2.05% |
| 13 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 105,500 | $4.4M | 1.90% |
| 14 | SOLENO THERAPEUTICS INC | SLNO | 94,600 | $4.3M | 1.82% |
| 15 | RHYTHM PHARMACEUTICALS INC | RYTM | 75,000 | $4.2M | 1.80% |
| 16 | ASTRAZENECA PLC | AZN | 30,000 | $3.9M | 1.69% |
| 17 | INSMED INC | INSM | 56,337 | $3.9M | 1.67% |
| 18 | BIOHAVEN LTD | BHVN | 100,000 | $3.7M | 1.60% |
| 19 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 43,700 | $3.6M | 1.57% |
| 20 | ASCENDIS PHARMA A/S | ASND | 25,276 | $3.5M | 1.49% |
| 21 | INSMED INC | INSM | 50,000 | $3.5M | 1.48% |
| 22 | AGIOS PHARMACEUTICALS INC | AGIO | 102,000 | $3.4M | 1.44% |
| 23 | TARSUS PHARMACEUTICALS INC | TARS | 60,000 | $3.3M | 1.43% |
| 24 | SOLENO THERAPEUTICS INC | SLNO | 71,988 | $3.2M | 1.39% |
| 25 | APELLIS PHARMACEUTICALS INC | APLS | 100,000 | $3.2M | 1.37% |
| 26 | ANAPTYSBIO INC | ANABV | 215,000 | $2.8M | 1.22% |
| 27 | CAPRICOR THERAPEUTICS INC | CAPR | 200,000 | $2.8M | 1.18% |
| 28 | BRIDGEBIO PHARMA INC | BBIO | 100,000 | $2.7M | 1.18% |
| 29 | CELLDEX THERAPEUTICS INC NEW | CLDX | 100,000 | $2.5M | 1.08% |
| 30 | ARCUS BIOSCIENCES INC | RCUS | 165,965 | $2.5M | 1.06% |
| 31 | SCHOLAR ROCK HLDG CORP | SRRK | 53,160 | $2.3M | 0.99% |
| 32 | APOGEE THERAPEUTICS INC | APGE | 50,620 | $2.3M | 0.98% |
| 33 | CENTESSA PHARMACEUTICALS PLC | CNTA | 131,862 | $2.2M | 0.95% |
| 34 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 52,300 | $2.2M | 0.94% |
| 35 | RELAY THERAPEUTICS INC | RLAY | 505,778 | $2.1M | 0.89% |
| 36 | KEROS THERAPEUTICS INC | KROS | 130,000 | $2.1M | 0.88% |
| 37 | RECURSION PHARMACEUTICALS IN | RXRX | 300,000 | $2.0M | 0.87% |
| 38 | SCHOLAR ROCK HLDG CORP | SRRK | 43,000 | $1.9M | 0.80% |
| 39 | JAZZ PHARMACEUTICALS PLC | JAZZ | 14,719 | $1.8M | 0.78% |
| 40 | UNIQURE NV | QURE | 100,000 | $1.8M | 0.76% |
| 41 | ORIC PHARMACEUTICALS INC | ORIC | 214,291 | $1.7M | 0.74% |
| 42 | ALTIMMUNE INC | ALT | 200,000 | $1.4M | 0.62% |
| 43 | TG THERAPEUTICS INC | TGTX | 47,805 | $1.4M | 0.62% |
| 44 | REPLIMUNE GROUP INC | REPL | 114,000 | $1.4M | 0.59% |
| 45 | CRINETICS PHARMACEUTICALS IN | CRNX | 25,900 | $1.3M | 0.57% |
| 46 | ANAPTYSBIO INC | ANABV | 100,000 | $1.3M | 0.57% |
| 47 | VISTAGEN THERAPEUTICS INC | VTGN | 442,520 | $1.3M | 0.56% |
| 48 | DENALI THERAPEUTICS INC | DNLI | 60,000 | $1.2M | 0.52% |
| 49 | NUVALENT INC | NUVL | 14,701 | $1.2M | 0.49% |
| 50 | EVOLUS INC | EOLS | 97,423 | $1.1M | 0.46% |
| 51 | KEROS THERAPEUTICS INC | KROS | 63,547 | $1.0M | 0.43% |
| 52 | BIONTECH SE | BNTX | 8,767 | $999,000 | 0.43% |
| 53 | VIRIDIAN THERAPEUTICS INC | VRDN | 49,478 | $948,493 | 0.41% |
| 54 | AMICUS THERAPEUTICS INC | FOLD | 100,000 | $942,000 | 0.40% |
| 55 | JANUX THERAPEUTICS INC | JANX | 17,500 | $936,950 | 0.40% |
| 56 | OCULAR THERAPEUTIX INC | OCUL | 104,000 | $888,160 | 0.38% |
| 57 | CASSAVA SCIENCES INC | 14817C107 | 371,300 | $876,268 | 0.38% |
| 58 | NEUMORA THERAPEUTICS INC. | NMRA | 81,200 | $860,720 | 0.37% |
| 59 | VAXCYTE INC | PCVX | 10,000 | $818,600 | 0.35% |
| 60 | CAPRICOR THERAPEUTICS INC | CAPR | 58,700 | $810,060 | 0.35% |
| 61 | KEROS THERAPEUTICS INC | KROS | 50,400 | $797,832 | 0.34% |
| 62 | ARCELLX INC | ACLX | 10,100 | $774,569 | 0.33% |
| 63 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 100,000 | $740,000 | 0.32% |
| 64 | VIR BIOTECHNOLOGY INC | VIR | 100,000 | $734,000 | 0.31% |
| 65 | GH RESEARCH PLC | GHRS | 101,502 | $710,514 | 0.30% |
| 66 | GERON CORP | GERN | 200,000 | $708,000 | 0.30% |
| 67 | COGENT BIOSCIENCES INC | COGT | 90,000 | $702,000 | 0.30% |
| 68 | CLIMB BIO INC | CLYM | 374,423 | $673,961 | 0.29% |
| 69 | NEKTAR THERAPEUTICS | NKTR | 698,919 | $649,995 | 0.28% |
| 70 | UROGEN PHARMA LTD | URGN | 50,000 | $532,500 | 0.23% |
| 71 | AEROVATE THERAPEUTICS INC | 008064107 | 191,600 | $507,740 | 0.22% |
| 72 | ALECTOR INC | ALEC | 239,019 | $451,746 | 0.19% |
| 73 | ARGENX SE | ARGX | 679 | $422,026 | 0.18% |
| 74 | BEIGENE LTD | BEIGF | 30,000 | $421,725 | 0.18% |
| 75 | PROQR THRAPEUTICS N V | N71542109 | 158,023 | $418,761 | 0.18% |
| 76 | RELAY THERAPEUTICS INC | RLAY | 100,000 | $412,000 | 0.18% |
| 77 | ERASCA INC | ERAS | 156,973 | $394,002 | 0.17% |
| 78 | SUMMIT THERAPEUTICS INC | SMMT | 20,000 | $356,900 | 0.15% |
| 79 | ZEVRA THERAPEUTICS INC | ZVRA | 42,081 | $350,956 | 0.15% |
| 80 | ALX ONCOLOGY HLDGS INC | ALXO | 197,680 | $330,126 | 0.14% |
| 81 | ELEDON PHARMACEUTICALS INC | ELDN | 75,794 | $312,271 | 0.13% |
| 82 | ECO WAVE POWER GLOBAL AB | WAVE | 23,600 | $291,932 | 0.13% |
| 83 | C4 THERAPEUTICS INC | CCCC | 80,100 | $288,360 | 0.12% |
| 84 | CANDEL THERAPEUTICS INC | CADL | 32,900 | $285,572 | 0.12% |
| 85 | TERNS PHARMACEUTICALS INC | TERN | 50,370 | $279,050 | 0.12% |
| 86 | BIOMEA FUSION INC | BMEA | 71,400 | $277,032 | 0.12% |
| 87 | GOSSAMER BIO INC | GOSS | 256,900 | $232,392 | 0.10% |
| 88 | GOSSAMER BIO INC | GOSS | 217,987 | $197,191 | 0.08% |
| 89 | CANDEL THERAPEUTICS INC | CADL | 20,000 | $173,600 | 0.07% |
| 90 | SUMMIT THERAPEUTICS INC | SMMT | 8,500 | $151,683 | 0.07% |
| 91 | Q32 BIO INC | QTTB | 35,100 | $120,744 | 0.05% |
| 92 | SAB BIOTHERAPEUTICS INC | SABSW | 30,000 | $113,826 | 0.05% |
| 93 | CHIMERIX INC | 16934W106 | 29,082 | $101,205 | 0.04% |
| 94 | KODIAK SCIENCES INC | KOD | 7,300 | $72,635 | 0.03% |
| 95 | Q32 BIO INC | QTTB | 19,700 | $67,768 | 0.03% |
| 96 | LARIMAR THERAPEUTICS INC | LRMR | 16,900 | $65,403 | 0.03% |
| 97 | ALX ONCOLOGY HLDGS INC | ALXO | 38,900 | $64,963 | 0.03% |
| 98 | ARVINAS INC | ARVN | 2,300 | $44,091 | 0.02% |
| 99 | EDGEWISE THERAPEUTICS INC | EWTX | 1,359 | $36,285 | 0.02% |
| 100 | ARS PHARMACEUTICALS INC | SPRY | 3,200 | $33,760 | 0.01% |
| 101 | MIND MEDICINE MINDMED INC | 60255C885 | 4,710 | $32,782 | 0.01% |
| 102 | LAVA THERAPEUTICS NV | N51517105 | 21,508 | $20,454 | 0.01% |
| 103 | Q32 BIO INC | QTTB | 5,600 | $19,264 | 0.01% |
| 104 | APTEVO THERAPEUTICS INC | APVO | 4,050 | $17,456 | 0.01% |
| 105 | LARIMAR THERAPEUTICS INC | LRMR | 3,800 | $14,706 | 0.01% |
| 106 | LEXICON PHARMACEUTICALS INC | LXRX | 800 | $591 | 0.00% |
| 107 | VISTAGEN THERAPEUTICS INC | VTGN | 200 | $590 | 0.00% |